CNR Institutional Research Information System

CUTRUPI, SEBASTIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 128
NA - Nord America 34
EU - Europa 22
Totale 184
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 125
US - Stati Uniti d'America 34
IT - Italia 18
KR - Corea 2
AT - Austria 1
CN - Cina 1
FR - Francia 1
GB - Regno Unito 1
NL - Olanda 1
Totale 184
Salva come PNG Salva come JPEG
Città #
Singapore 89
Santa Clara 10
Catania 2
Milan 2
Seoul 2
Amsterdam 1
London 1
Naples 1
Paris 1
Rozzano 1
Vienna 1
Totale 111
Salva come PNG Salva come JPEG
Nome #
Role of Gut Microbiota in Overweight Susceptibility in an Adult Population in Italy 29
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass 10
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial 6
L'obesità addominale interagisce con due citochine prodotte dal tessuto adiposo, Leptina ed Adiponectina, per predire il rischio di mortalità totale e cardiovascolare nei pazienti in dialisi. 5
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 4
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. 4
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study 4
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Myocardial Injury in Patients Undergoing Cardiopulmonary Bypass 4
Osteopontin, death and cardiovascular events in stage G3–4 CKD patients: a joint model analysis 3
INDICES OF INSULIN RESISTANCE AND RISK OF TOTAL AND CARDIOVASCULAR MORTALITY IN DIALYSIS PATIENTS 3
C-Reactive Protein and Interleukin-6 modify the risk of high levels of Asymmetric Dimethyl-Arginine (ADMA) for death and cardiovascular events in end stage renal diseases patients. 3
Urotensin II in end-stage renal disease: an inverse correlate of sympathetic function and cardiac natriuretic peptides 3
Serum phosphate modifies the vascular response to vitamin D receptor activation in chronic kidney disease (CKD) patients 3
Intact FGF23 and -klotho during acute inflammation/sepsis in CKD patients 3
La riduzione dell'intake di sale influenza l'infiammazione nell'ipertensione arteriosa essenziale? 3
Functional correlates and gene expression in fat cells of visfatin/pre-b cell enhancing factor in CKD patients. 3
L'ipotiroidismo subclinico si associa alla micro-infiammazione cronica e predice la mortalità nei pazienti in CAPD. Risultati di uno studio pilota di coorte. 3
Smoking and hyperparathyroidism in patients with end-stage renal disease (ESRD). 3
Waist circumference modifies the relationship of adipose tissue cytochines leptin and adiponectin with all-cause and cardiovascular mortality in end stage renal disease (ESRD). 3
L'infiammazione amplifica il rischio di mortalità ed eventi cardiovascolari connesso ai livelli circolanti di dimetilarginina asimmetrica (ADMA) nei pazienti in dialisi. 3
Raised Asymmetric Dimethyl Arginine (ADMA) is associated with high Plasma Norepinephrine (NE) in patients with End Stage Renal Disease (ESRD). 2
Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients 2
Il rischio di progressione delle nefropatie croniche e mortalità: ruolo dell'Asymmetrical Di-Methil-Arginine (ADMA). 2
Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure. 2
Urotensin II is inversely related to markers of endothelial activation and inflammation and is an inverse predictor of incident cardiovascolar events in end stage renal disease (ESRD). 2
Sympathetic activity and asymmetric dimethyl arginine (ADMA) in patients with end stage renal disease (ESRD). 2
Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial 2
Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcome stage renal disease patients. 2
Low Triiodothyronine and Cardiomyopathy in Patients with End-Stage Renal Disease (ESRD). 2
L'iperparatiroidismo e il TNF-a come determinanti dell'incidenza di fratture nei pazienti in dialisi: uno studio di coorte. 2
Salt intake and inflammation in essential hypertension. 2
Insulin Sensitivity, Systemic Inflammation and Adipose Tissue Gene Expression of Inflammatory Cytokines in Chronic Kidney Disease (CKD) and in Obese Patients. 2
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure. 2
FGF23 beyond bone mineral metabolism: functional relationship with inflammation in chronic kidney disease patients. 2
Low triiodothyronine and survival in end-stage renal disease. 2
Vascular Endothelial Growth Factor, rimodellamento ventricolare sinistro e disfunzione sistolica nei pazienti in dialisi 2
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD) 2
Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease. 2
L'attività simpatica è strettamente correlata ai livelli corcolanti di dimetil arginina asimmetrica (ADMA) nei pazienti in trattamento emodialitico 2
Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients 2
Beyond bone mineral metabolism: functional relationship with inflammation in chronic kidney disease (CKD) patients. 2
La riduzione dell'intake di sale influenza l'infiammazione nell'ipertensione arteriosa essenziale? 2
Circulating soluble RAGE in patients with chronic kidney disease as an inverse correlate of atherosclerosis. 2
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease 2
I polimorfismi del gene ENPP1 si associano ad ipertrofia ventricolare sinistra ed alla funzione sistolica nei pazienti in dialisi. 2
Adiponectin, the most abundant adipocyte-derived protein, is functionally related to metabolic risk factors and predicts cardiovascular events in patients with end stage renal disease 2
I predittori degli eventi cardiovascolari nei pazienti in dialisi. 2
Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. 2
Urotensin II and biomarkers of endothelial activation and atherosclerosis in end stage renal disease (ESRD). 2
Intact FGF23 and ?-klotho during acute inflammation/sepsis in CKD patients 2
Resistin and all-cause and cardiovascular mortality: Effect modification by adiponectin in end-stage kidney disease patients 2
La riduzione dell intake di sale influenza l infiammazione nell ipertensione arteriosa essenziale? 2
Salivary and lacrimal secretion is reduced in patients with ESRD. 2
Inflammation downregulates FGF23 in chronic kidney disease (CKD) patients. 1
Prospective study of Neuropeptide Y as an adverse cardiovascular risk factor in end-stage renal disease. 1
Diagnostic value of troponin-t for alterations in left ventricular mass and function in dialysis patients 1
Urotensin II and cardiomyopathy in end-stage renal disease. 1
Urotensin II partecipates in cardiovascular control in end stage renal disease (ESRD). 1
Pattern evolutivo dei biomarcatori di infiammazione e dei fattori di rischio non tradizionali dopo trapianto renale. 1
Vitamin D levels and patient outcome in chronic kidney disease. 1
Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease 1
Thyroid sick syndrome e miocardiopatia nei pazienti con insufficienza renale cronica. 1
Which is the best inflammation marker? A comparative study based on multivariate modelling of mortality in end stage renal disease (ESRD) patients. 1
Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD). 1
La concentrazione plasmatica di Neuropeptide Y è correlata ai livelli circolanti di Noradrenalina e predice l'incidenza di eventi cardiovascolari (CV) nei pazienti in dialisi. 1
Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD 1
Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease 1
Diagnostic value for low bone turnover of first and second generation immuno-radiometric PTH assay. 1
Low Triiodothyronine (fT3): a new facet of inflammation in end stage renale disease (ESRD). 1
Functional correlates and gene expression in fat cells of visfatin/pre-b cell enhancing factor in ckd patients. 1
Neuropeptide Y (NPY), norepinephrine and incident cardiovascular events in and-tage renal disease (ESRD). 1
Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients. 1
Norepinephrine and concentric hypertrophy in patients with end stage renal disease. 1
Urotensina II e fattori di rischio cardiovascolare nei pazienti con insufficienza renale cronica in trattamento dialitico. 1
Asymmetrical Di-Methyl-Arginine (ADMA) predicts progression to dialysis and death in patients with chronic kidney disease (CKD). 1
Plasma nor-epinephrine predicts survival and incident cardiovascular events in patients with end stage renal disease 1
Insulin Sensitivity, Systemic Inflammation and Adipose Tissue Gene Expression of Inflammatory Cytokines in Chronic Kidney Disease (CKD) and in Obese Patients. 1
Smoking and hyperparathyroidism in patients with end stage renal disease (ESRD). 1
Inflammation downregulates FGF23 in chronic kidney disease (CKD) patients. 1
La riduzione dell'intake di sale influenza l'infiammazione nell'ipertensione arteriosa essenziale? 1
Vascular endothelial growth factor (VRGF) is a marker of left ventricular dysfunction and predicts mortality in hemodialysis (HD) patients. 1
Il fumo amplifica il rischio di iperparatiroidismo secondario nei pazienti in dialisi. 1
Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis 1
Circulating soluble RAGE in patients with chronic kidney disease as an inverse correlate of atherosclerosis. 1
Vascular Endothelial Growth Factor, Inflammation, Cardiomyopathy and Mortality in End-Stage-Renal Disease (ESRD) 1
Low triiodothyronine and survival in end stage renal disease (ESRD). 1
Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic kidney disease. 1
Vascular endothelial growth factor, left ventricular remodeling and systolic dysfunction in end stage renal disease 1
Urotensin II and biomarkers of endothelial activation and atherosclerosis in end-stage renal disease 1
Livelli circolanti di tiiodrotironina (fT3) e mortalità nei pazienti in dialisi. 1
Valore diagnostico per il basso turnover osseo del PTH dosato con metodi RIA di prima e seconda generazione. 1
Does sub-clinical hypothyroidism predict survival in patients on Continuous Ambulatory Peritoneal Dialysis? 1
Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections 1
Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortatlity in hemodialysis patients. 1
Totale 209
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.516
article - articoli 768
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.284
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202427 0 0 0 0 0 0 0 0 24 0 3 0
2024/2025182 5 9 94 74 0 0 0 0 0 0 0 0
Totale 209